This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trkola, A.
Right arrow Articles by Moore, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trkola, A.
Right arrow Articles by Moore, J. P.

 Previous Article  |  Next Article 

J. Virol., 01 1998, 396-404, Vol 72, No. 1
Copyright © 1998, American Society for Microbiology

Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines

A Trkola, WA Paxton, SP Monard, JA Hoxie, MA Siani, DA Thompson, L Wu, CR Mackay, R Horuk and JP Moore
The Aaron Diamond AIDS Research Center, The Rockefeller University, New York, New York 10021, USA.

We have studied the breadth and potency of the inhibitory actions of the CC chemokines macrophage inhibitory protein 1alpha (MIP-1alpha), MIP-1beta, and RANTES against macrophage-tropic (M-tropic) primary isolates of human immunodeficiency virus type 1 (HIV-1) and of the CXC chemokine stromal cell-derived factor 1alpha against T-cell-tropic (T- tropic) isolates, using mitogen-stimulated primary CD4+ T cells as targets. There was considerable interisolate variation in the sensitivity of HIV-1 to chemokine inhibition, which was especially pronounced for the CC chemokines and M-tropic strains. However, this variation was not obviously dependent on the genetic subtype (A through F) of the virus isolates. Peripheral blood mononuclear cell donor- dependent variation in chemokine inhibition potency was also observed. Among the CC chemokines, the rank order for potency (from most to least potent) was RANTES, MIP-1beta, MIP-1alpha. Some M-tropic isolates, unexpectedly, were much more sensitive to RANTES than to MIP-1beta, whereas other isolates showed sensitivities comparable to those of these two chemokines. Down-regulation of the CCR5 and CXCR4 receptors occurred in cells treated with the cognate chemokines and probably contributes to anti-HIV-1 activity. Thus, for CCR5, the rank order for down-regulation was also RANTES, MIP-1beta, MIP-1alpha.


This article has been cited by other articles:

  • Gaertner, H., Cerini, F., Escola, J.-M., Kuenzi, G., Melotti, A., Offord, R., Rossitto-Borlat, I., Nedellec, R., Salkowitz, J., Gorochov, G., Mosier, D., Hartley, O. (2008). Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide. Proc. Natl. Acad. Sci. USA 105: 17706-17711 [Abstract] [Full Text]  
  • Lobritz, M. A., Marozsan, A. J., Troyer, R. M., Arts, E. J. (2007). Natural Variation in the V3 Crown of Human Immunodeficiency Virus Type 1 Affects Replicative Fitness and Entry Inhibitor Sensitivity. J. Virol. 81: 8258-8269 [Abstract] [Full Text]  
  • Rusert, P., Kuster, H., Joos, B., Misselwitz, B., Gujer, C., Leemann, C., Fischer, M., Stiegler, G., Katinger, H., Olson, W. C., Weber, R., Aceto, L., Gunthard, H. F., Trkola, A. (2005). Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors. J. Virol. 79: 8454-8469 [Abstract] [Full Text]  
  • Karlsson, I., Antonsson, L., Shi, Y., Oberg, M., Karlsson, A., Albert, J., Olde, B., Owman, C., Jansson, M., Fenyo, E. M. (2004). Coevolution of RANTES Sensitivity and Mode of CCR5 Receptor Use by Human Immunodeficiency Virus Type 1 of the R5 Phenotype. J. Virol. 78: 11807-11815 [Abstract] [Full Text]  
  • Nabatov, A. A., Pollakis, G., Linnemann, T., Kliphius, A., Chalaby, M. I. M., Paxton, W. A. (2004). Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies. J. Virol. 78: 524-530 [Abstract] [Full Text]  
  • Trkola, A., Kuster, H., Leemann, C., Ruprecht, C., Joos, B., Telenti, A., Hirschel, B., Weber, R., Bonhoeffer, S., Gunthard, H. F. (2003). Human Immunodeficiency Virus Type 1 Fitness Is a Determining Factor in Viral Rebound and Set Point in Chronic Infection. J. Virol. 77: 13146-13155 [Abstract] [Full Text]  
  • Gross, E., Amella, C. A., Pompucci, L., Franchin, G., Sherry, B., Schmidtmayerova, H. (2003). Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection. J. Leukoc. Biol. 74: 781-790 [Abstract] [Full Text]  
  • Roscic-Mrkic, B., Fischer, M., Leemann, C., Manrique, A., Gordon, C. J., Moore, J. P., Proudfoot, A. E. I., Trkola, A. (2003). RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 102: 1169-1177 [Abstract] [Full Text]  
  • Polonis, V. R., Souza, M. S. d., Darden, J. M., Chantakulkij, S., Chuenchitra, T., Nitayaphan, S., Brown, A. E., Robb, M. L., Birx, D. L. (2003). Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Resistance Is Associated with the Syncytium-Inducing Phenotype and Lower CD4 Cell Counts in Subtype CRF01_AE-Infected Patients. J. Virol. 77: 8570-8576 [Abstract] [Full Text]  
  • Tsamis, F., Gavrilov, S., Kajumo, F., Seibert, C., Kuhmann, S., Ketas, T., Trkola, A., Palani, A., Clader, J. W., Tagat, J. R., McCombie, S., Baroudy, B., Moore, J. P., Sakmar, T. P., Dragic, T. (2003). Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry. J. Virol. 77: 5201-5208 [Abstract] [Full Text]  
  • Cilliers, T., Nhlapo, J., Coetzer, M., Orlovic, D., Ketas, T., Olson, W. C., Moore, J. P., Trkola, A., Morris, L. (2003). The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C. J. Virol. 77: 4449-4456 [Abstract] [Full Text]  
  • Ketas, T. J., Frank, I., Klasse, P. J., Sullivan, B. M., Gardner, J. P., Spenlehauer, C., Nesin, M., Olson, W. C., Moore, J. P., Pope, M. (2003). Human Immunodeficiency Virus Type 1 Attachment, Coreceptor, and Fusion Inhibitors Are Active against both Direct and trans Infection of Primary Cells. J. Virol. 77: 2762-2767 [Abstract] [Full Text]  
  • Pastore, C., Picchio, G. R., Galimi, F., Fish, R., Hartley, O., Offord, R. E., Mosier, D. E. (2003). Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES. Antimicrob. Agents Chemother. 47: 509-517 [Abstract] [Full Text]  
  • An, P., Nelson, G. W., Wang, L., Donfield, S., Goedert, J. J., Phair, J., Vlahov, D., Buchbinder, S., Farrar, W. L., Modi, W., O'Brien, S. J., Winkler, C. A. (2002). Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl. Acad. Sci. USA 99: 10002-10007 [Abstract] [Full Text]  
  • Gorry, P. R., Taylor, J., Holm, G. H., Mehle, A., Morgan, T., Cayabyab, M., Farzan, M., Wang, H., Bell, J. E., Kunstman, K., Moore, J. P., Wolinsky, S. M., Gabuzda, D. (2002). Increased CCR5 Affinity and Reduced CCR5/CD4 Dependence of a Neurovirulent Primary Human Immunodeficiency Virus Type 1 Isolate. J. Virol. 76: 6277-6292 [Abstract] [Full Text]  
  • Munch, J., Standker, L., Pohlmann, S., Baribaud, F., Papkalla, A., Rosorius, O., Stauber, R., Sass, G., Heveker, N., Adermann, K., Escher, S., Kluver, E., Doms, R. W., Forssmann, W.-G., Kirchhoff, F. (2002). Hemofiltrate CC Chemokine 1[9-74] Causes Effective Internalization of CCR5 and Is a Potent Inhibitor of R5-Tropic Human Immunodeficiency Virus Type 1 Strains in Primary T Cells and Macrophages. Antimicrob. Agents Chemother. 46: 982-990 [Abstract] [Full Text]  
  • Chang, T. L.-Y., Gordon, C. J., Roscic-Mrkic, B., Power, C., Proudfoot, A. E. I., Moore, J. P., Trkola, A. (2002). Interaction of the CC-Chemokine RANTES with Glycosaminoglycans Activates a p44/p42 Mitogen-Activated Protein Kinase-Dependent Signaling Pathway and Enhances Human Immunodeficiency Virus Type 1 Infectivity. J. Virol. 76: 2245-2254 [Abstract] [Full Text]  
  • Trkola, A., Kuhmann, S. E., Strizki, J. M., Maxwell, E., Ketas, T., Morgan, T., Pugach, P., Xu, S., Wojcik, L., Tagat, J., Palani, A., Shapiro, S., Clader, J. W., McCombie, S., Reyes, G. R., Baroudy, B. M., Moore, J. P. (2002). HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use. Proc. Natl. Acad. Sci. USA 99: 395-400 [Abstract] [Full Text]  
  • Marozsan, A. J., Torre, V. S., Johnson, M., Ball, S. C., Cross, J. V., Templeton, D. J., Quinones-Mateu, M. E., Offord, R. E., Arts, E. J. (2001). Mechanisms Involved in Stimulation of Human Immunodeficiency Virus Type 1 Replication by Aminooxypentane RANTES. J. Virol. 75: 8624-8638 [Abstract] [Full Text]  
  • Dragic, T. (2001). An overview of the determinants of CCR5 and CXCR4 co-receptor function. J. Gen. Virol. 82: 1807-1814 [Full Text]  
  • Hogan, C. M., Hammer, S. M. (2001). Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics. ANN INTERN MED 134: 978-996 [Abstract] [Full Text]  
  • Yonezawa, A., Hori, T., Takaori-Kondo, A., Morita, R., Uchiyama, T. (2001). Replacement of the V3 Region of gp120 with SDF-1 Preserves the Infectivity of T-Cell Line-Tropic Human Immunodeficiency Virus Type 1. J. Virol. 75: 4258-4267 [Abstract] [Full Text]  
  • Aquaro, S., Menten, P., Struyf, S., Proost, P., Van Damme, J., De Clercq, E., Schols, D. (2001). The LD78{beta} Isoform of MIP-1{alpha} Is the Most Potent CC-Chemokine in Inhibiting CCR5-Dependent Human Immunodeficiency Virus Type 1 Replication in Human Macrophages. J. Virol. 75: 4402-4406 [Abstract] [Full Text]  
  • Trkola, A., Ketas, T. J., Nagashima, K. A., Zhao, L., Cilliers, T., Morris, L., Moore, J. P., Maddon, P. J., Olson, W. C. (2001). Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140. J. Virol. 75: 579-588 [Abstract] [Full Text]  
  • Blanpain, C., Lee, B., Tackoen, M., Puffer, B., Boom, A., Libert, F., Sharron, M., Wittamer, V., Vassart, G., Doms, R. W., Parmentier, M. (2000). Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood 96: 1638-1645 [Abstract] [Full Text]  
  • Zhang, Y.-j., Lou, B., Lal, R. B., Gettie, A., Marx, P. A., Moore, J. P. (2000). Use of Inhibitors To Evaluate Coreceptor Usage by Simian and Simian/Human Immunodeficiency Viruses and Human Immunodeficiency Virus Type 2 in Primary Cells. J. Virol. 74: 6893-6910 [Abstract] [Full Text]  
  • Ruppach, H., Nara, P., Raudonat, I., Elanjikal, Z., Rübsamen-Waigmann, H., Dietrich, U. (2000). Human Immunodeficiency Virus (HIV)-Positive Sera Obtained Shortly after Seroconversion Neutralize Autologous HIV Type 1 Isolates on Primary Macrophages but Not on Lymphocytes. J. Virol. 74: 5403-5411 [Abstract] [Full Text]  
  • Owen, S. M., Masciotra, S., Novembre, F., Yee, J., Switzer, W. M., Ostyula, M., Lal, R. B. (2000). Simian Immunodeficiency Viruses of Diverse Origin Can Use CXCR4 as a Coreceptor for Entry into Human Cells. J. Virol. 74: 5702-5708 [Abstract] [Full Text]  
  • Torre, V. S., Marozsan, A. J., Albright, J. L., Collins, K. R., Hartley, O., Offord, R. E., Quiñones-Mateu, M. E., Arts, E. J. (2000). Variable Sensitivity of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates to Inhibition by RANTES Analogs. J. Virol. 74: 4868-4876 [Abstract] [Full Text]  
  • Lopalco, L., Barassi, C., Pastori, C., Longhi, R., Burastero, S. E., Tambussi, G., Mazzotta, F., Lazzarin, A., Clerici, M., Siccardi, A. G. (2000). CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro. J. Immunol. 164: 3426-3433 [Abstract] [Full Text]  
  • Doranz, B. J., Baik, S. S. W., Doms, R. W. (1999). Use of a gp120 Binding Assay To Dissect the Requirements and Kinetics of Human Immunodeficiency Virus Fusion Events. J. Virol. 73: 10346-10358 [Abstract] [Full Text]  
  • Trkola, A., Matthews, J., Gordon, C., Ketas, T., Moore, J. P. (1999). A Cell Line-Based Neutralization Assay for Primary Human Immunodeficiency Virus Type 1 Isolates That Use either the CCR5 or the CXCR4 Coreceptor. J. Virol. 73: 8966-8974 [Abstract] [Full Text]  
  • Creson, J. R., Lin, A. A., Li, Q., Broad, D. F., Roberts, M. R., Anderson, S. J. (1999). The Mode and Duration of Anti-CD28 Costimulation Determine Resistance to Infection by Macrophage-Tropic Strains of Human Immunodeficiency Virus Type 1 In Vitro. J. Virol. 73: 9337-9347 [Abstract] [Full Text]  
  • Cladera, J., Martin, I., Ruysschaert, J.-M., O'Shea, P. (1999). Characterization of the Sequence of Interactions of the Fusion Domain of the Simian Immunodeficiency Virus with Membranes. ROLE OF THE MEMBRANE DIPOLE POTENTIAL. J. Biol. Chem. 274: 29951-29959 [Abstract] [Full Text]  
  • Moir, S., Lapointe, R., Malaspina, A., Ostrowski, M., Cole, C. E., Chun, T.-W., Adelsberger, J., Baseler, M., Hwu, P., Fauci, A. S. (1999). CD40-Mediated Induction of CD4 and CXCR4 on B Lymphocytes Correlates with Restricted Susceptibility to Human Immunodeficiency Virus Type 1 Infection: Potential Role of B Lymphocytes as a Viral Reservoir. J. Virol. 73: 7972-7980 [Abstract] [Full Text]  
  • Greco, G., Mackewicz, C., Levy, J. A. (1999). Sensitivity of human immunodeficiency virus infection to various {alpha}, {beta} and {gamma} chemokines. J. Gen. Virol. 80: 2369-2373 [Abstract] [Full Text]  
  • Trkola, A., Gordon, C., Matthews, J., Maxwell, E., Ketas, T., Czaplewski, L., Proudfoot, A. E. I., Moore, J. P. (1999). The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That Enhances Viral Infectivity. J. Virol. 73: 6370-6379 [Abstract] [Full Text]  
  • Worgall, S., Connor, R., Kaner, R. J., Fenamore, E., Sheridan, K., Singh, R., Crystal, R. G. (1999). Expression and Use of Human Immunodeficiency Virus Type 1 Coreceptors by Human Alveolar Macrophages. J. Virol. 73: 5865-5874 [Abstract] [Full Text]  
  • Nibbs, R. J. B., Yang, J., Landau, N. R., Mao, J.-H., Graham, G. J. (1999). LD78beta , A Non-allelic Variant of Human MIP-1alpha (LD78alpha ), Has Enhanced Receptor Interactions and Potent HIV Suppressive Activity. J. Biol. Chem. 274: 17478-17483 [Abstract] [Full Text]  
  • Olson, W. C., Rabut, G. E. E., Nagashima, K. A., Tran, D. N. H., Anselma, D. J., Monard, S. P., Segal, J. P., Thompson, D. A. D., Kajumo, F., Guo, Y., Moore, J. P., Maddon, P. J., Dragic, T. (1999). Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5. J. Virol. 73: 4145-4155 [Abstract] [Full Text]  
  • Doranz, B. J., Orsini, M. J., Turner, J. D., Hoffman, T. L., Berson, J. F., Hoxie, J. A., Peiper, S. C., Brass, L. F., Doms, R. W. (1999). Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions. J. Virol. 73: 2752-2761 [Abstract] [Full Text]  
  • Zhang, Y.-j., Moore, J. P. (1999). Will Multiple Coreceptors Need To Be Targeted by Inhibitors of Human Immunodeficiency Virus Type 1 Entry?. J. Virol. 73: 3443-3448 [Abstract] [Full Text]  
  • Caufour, P, Le Grand, R, Cheret, A, Neildez, O, Theodoro, F, Boson, B, Vaslin, B, Dormont, D (1999). Secretion of beta-chemokines by bronchoalveolar lavage cells during primary infection of macaques inoculated with attenuated nef-deleted or pathogenic simian immunodeficiency virus strain mac251. J. Gen. Virol. 80: 767-776 [Abstract]  
  • Lee, B., Ratajczak, J., Doms, R. W., Gewirtz, A. M., Ratajczak, M. Z. (1999). Coreceptor/Chemokine Receptor Expression on Human Hematopoietic Cells: Biological Implications for Human Immunodeficiency Virus-Type 1 Infection. Blood 93: 1145-1156 [Abstract] [Full Text]  
  • Greco, G., Fujimura, S. H., Mourich, D. V., Levy, J. A. (1999). Differential Effects of Human Immunodeficiency Virus Isolates on beta -Chemokine and Gamma Interferon Production and on Cell Proliferation. J. Virol. 73: 1528-1534 [Abstract] [Full Text]  
  • Gordon, C. J., Muesing, M. A., Proudfoot, A. E. I., Power, C. A., Moore, J. P., Trkola, A. (1999). Enhancement of Human Immunodeficiency Virus Type 1 Infection by the CC-Chemokine RANTES Is Independent of the Mechanism of Virus-Cell Fusion. J. Virol. 73: 684-694 [Abstract] [Full Text]  
  • Zhang, Y.-j., Dragic, T., Cao, Y., Kostrikis, L., Kwon, D. S., Littman, D. R., KewalRamani, V. N., Moore, J. P. (1998). Use of Coreceptors Other Than CCR5 by Non-Syncytium-Inducing Adult and Pediatric Isolates of Human Immunodeficiency Virus Type 1 Is Rare In Vitro. J. Virol. 72: 9337-9344 [Abstract] [Full Text]  
  • Montefiori, D. C., Collman, R. G., Fouts, T. R., Zhou, J. Y., Bilska, M., Hoxie, J. A., Moore, J. P., Bolognesi, D. P. (1998). Evidence that Antibody-Mediated Neutralization of Human Immunodeficiency Virus Type 1 by Sera from Infected Individuals Is Independent of Coreceptor Usage. J. Virol. 72: 1886-1893 [Abstract] [Full Text]  
  • Dragic, T., Trkola, A., Lin, S. W., Nagashima, K. A., Kajumo, F., Zhao, L., Olson, W. C., Wu, L., Mackay, C. R., Allaway, G. P., Sakmar, T. P., Moore, J. P., Maddon, P. J. (1998). Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry. J. Virol. 72: 279-285 [Abstract] [Full Text]  
  • Miyagi, T., Chuang, L. F., Doi, R. H., Carlos, M. P., Torres, J. V., Chuang, R. Y. (2000). Morphine Induces Gene Expression of CCR5 in Human CEM x174 Lymphocytes. J. Biol. Chem. 275: 31305-31310 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»